Atlas Trials

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Clinical trial NCT04770337 · COMPLETED

Trial details

NCT number
NCT04770337
Sponsor
Neuroelectrics Corporation
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Refractory EpilepsyFocal SeizureSeizures, FocalSeizuresEpilepsy in ChildrenEpilepsyEpilepsy, Tonic-Clonic
Start date
2021-10-25
Primary completion
2026-01-12
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.